News Alert: Serum institute seeks emergency use nod for 'Covishield' vaccine in India

Updated: Dec 07, 2020, 10:48 AM(IST)

The Serum Institute of India (SII) on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford COVID-19 vaccine 'Covishield' in the country,

Read in App